Compare WLDN & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLDN | IART |
|---|---|---|
| Founded | 1964 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2006 | 1996 |
| Metric | WLDN | IART |
|---|---|---|
| Price | $91.81 | $16.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | ★ $114.50 | $14.33 |
| AVG Volume (30 Days) | 450.6K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.89 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $273,352,000.00 | N/A |
| Revenue This Year | N/A | $4.39 |
| Revenue Next Year | $12.05 | $3.40 |
| P/E Ratio | $167.37 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $53.44 | $8.70 |
| 52 Week High | $137.00 | $16.62 |
| Indicator | WLDN | IART |
|---|---|---|
| Relative Strength Index (RSI) | 57.69 | 72.64 |
| Support Level | $86.37 | $12.64 |
| Resistance Level | $98.22 | $16.35 |
| Average True Range (ATR) | 4.99 | 0.86 |
| MACD | 0.26 | 0.09 |
| Stochastic Oscillator | 51.00 | 85.64 |
Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.